Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-08-11Prognostic Value of PDL1 in Ovarian High Grade Serous Carcinoma
-
CLINICAL_TRIALS study record update · 2020-08-10Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-08-07An Exploratory Study of αPD1-MSLN-CAR T Cells Secreting PD-1 Nanobodies for the Treatment of MSLN-positive Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-08-05Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-07-28A Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Arsenic Trioxide for Injection in Patients With Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-07-16PREDICT: Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region. A Prospective, Multi-centre, Epidemiological Observational Study Designed to Evaluate the Prevalence of BRCA1 and BRCA2 Mutations in Current and Newly Diagnosed Ovarian Cancer Patients Across Different Countries in the Gulf Region. This Study Study Will Also Describe the Epidemiological Features for the Disease for the Enrolled Patients.
-
CLINICAL_TRIALS study record update · 2020-07-15Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies
-
CLINICAL_TRIALS study record update · 2020-07-10Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study
-
CLINICAL_TRIALS study record update · 2020-07-08Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
-
CLINICAL_TRIALS study record update · 2020-07-01A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
-
CLINICAL_TRIALS study record update · 2020-06-30Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
-
CLINICAL_TRIALS study record update · 2020-06-22A Phase 1 Study to Evaluate the Safety and Tolerability of Anti-PD-L1, MEDI4736, in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-06-18Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
-
CLINICAL_TRIALS study record update · 2020-06-17A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-06-12A Phase II Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 Cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression.
-
CLINICAL_TRIALS study record update · 2020-06-09FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2020-05-29A Phase III Clinical Trail of Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-05-28A Phase Ib/II Study of CRLX101 in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-05-22Diaphragmatic Resection And Gynecological Ovarian Neoplasm
-
CLINICAL_TRIALS study record update · 2020-05-18Multicenter Prospective Randomized Controlled Clinical Trial of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After Primary Cytoreductive Surgery
-
CLINICAL_TRIALS study record update · 2020-05-12A Phase 2 Randomized, Open-label, Multicenter Trial of Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant or Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-05-06Cancer Screening and Prevention Program for High Risk Women
-
CLINICAL_TRIALS study record update · 2020-05-04Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients
-
CLINICAL_TRIALS study record update · 2020-04-29The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
-
CLINICAL_TRIALS study record update · 2020-04-20Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers